Apr 03,2015

Artificial pancreas software algorithm receives approval in europe

The Glucositter software algorithm has received a CE Mark in Europe, but the big question is when and how this software will reach patients. Currently, the system runs on a laptop, but a handheld device for patients is an ideal choice. DreaMed Diabetes is the company in charge of commercializing the closed-loop system consisting of software algorithm, pump, and continuous glucose monitoring (CGM).

REGULATORY CE MARK

#closed loop

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 14,2015

Dexcom G5® Mobile Continuous Glucose Monitoring System Receives CE Mark

The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System has received CE Mark (Conformite Europeenne) and will be available in several European countries in the coming weeks. This new system from Dexcom will be introduced to healthcare professionals and diabetes association delegates at the European Association for the Study of Diabetes (EASD) conference in Stockholm.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 14,2022

Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 16,2022

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems, today announced that it has received CE Mark approval for the next-generation Eversense® E3 CGM System, the longest-lasting system available, with exceptional accuracy.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
May 26,2021

One Drop Receives CE Mark, Launches Data-Driven Insights for People Managing High Blood Pressure

The CE-marked feature offers real-time insights on how a member’s blood pressure is trending, providing them the opportunity to mitigate risks associated with high blood pressure proactively.

REGULATORY CE MARK
View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

Eversense NOW Remote Monitoring App for Android Users Receives CE Mark in Europe

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it received CE mark of the Eversense® NOW Remote Monitoring App for the Android Operating System. The Eversense NOW iOS platform has previously been approved and is currently available in Europe.

REGULATORY CE MARK

#cgm

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 11,2020

Medtronic Secures CE Mark for MiniMed™ 780G Advanced Hybrid Closed Loop System Designed to Further Simplify Type 1 Diabetes Management

Medtronic plc(opens new window) (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years. Leveraging the company’s most advanced SmartGuard™ algorithm, the system automates the delivery of both basal insulin and correction boluses every five minutes to help people with diabetes avoid highs and lows with greater ease.

REGULATORY CE MARK

#closed loop

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 07,2020

Brighter expands the product portfolio - has received the CE mark for the new product "Actiste® Mini"

Brighter AB (publ) has today received EC certifications (CE marking) for its new product Actiste Mini – a smart and user-friendly blood glucose meter with global out-of-the-box connectivity via eSIM, which supports the successful management and supervision of diabetes.

REGULATORY CE MARK

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 28,2020

ABBOTT'S FREESTYLE® LIBRE 3 SYSTEM RECEIVES CE MARK - FEATURES WORLD'S SMALLEST, THINNEST SENSOR WITH BEST-IN-CLASS PERFORMANCE AT THE SAME LOW COST FOR PEOPLE WITH DIABETES

Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology,8 announced today it has secured CE Mark (Conformité Européenne) for its next-generation FreeStyle Libre 3 system, which is now approved for use by people living with diabetes in Europe. The FreeStyle Libre 3 technology provides continuous, real-time glucose readings automatically delivered to smartphones2 every minute, offering unsurpassed 14-day accuracy1 in the smallest and thinnest3 sensor design at the same affordable price7 as previous versions of the device.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 01,2020

Diabeloop introduces an automated management solution for highly unstable diabetes

Diabeloop announced today that it has obtained CE marking for its innovative and adjustable technological solution: DBL-hu. DBL-hu improves glycemic control and satisfaction for people living with a form of diabetes that is very complex to manage. Diabeloop expands its position in therapeutic artificial intelligence, following CE marking of DBLG1 in 2018.

REGULATORY CE MARK
View Analyst & Ambassador Comments
Go to original news
Subscribe to CE MARK